From: Effect of PFOA exposure on diminished ovarian reserve and its metabolism
PFOA DOR (ng/ml) | Q1 (4.45–13.96) | Q2 (14.29–38.67) | Q3 (62.86–155.82) | Q4 (182.23–485.43) | P value |
35.71% (2/12) | 41.67% (5/12) | 53.33% (8/15) | 33.33% (5/15) | 0.471 | |
PFOA NOR (ng/ml) | Q1 (1.69–2.67) | Q2 (2.68–3.32) | Q3 (3.54–3.64) | Q4 (3.75–28.89) | |
30.95% (13/42) | 47.50% (19/40) | 55% (22/40) | 39.22% (20/51) | 0.140 | |
PFOA PCOS (ng/ml) | Q1 (0.19–0.53) | Q2 (0.59–0.68) | Q3 (0.73–0.78) | Q4 (0.83–2.25) | |
51.28% (40/78) | 47.31% (44/93) | 60.76% (48/79) | 32.65% (32/98) | 0.002 |